These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12183721)

  • 1. Protein insufficiency and linear growth restriction in phenylketonuria.
    Arnold GL; Vladutiu CJ; Kirby RS; Blakely EM; Deluca JM
    J Pediatr; 2002 Aug; 141(2):243-6. PubMed ID: 12183721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body protein in prepubertal children with phenylketonuria.
    Allen JR; Baur LA; Waters DL; Humphries IR; Allen BJ; Roberts DC; Gaskin KJ
    Eur J Clin Nutr; 1996 Mar; 50(3):178-86. PubMed ID: 8654332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of prealbumin concentration as a biomarker of nutritional status in treated phenylketonuric patients.
    Rocha JC; Almeida MF; Carmona C; Cardoso ML; Borges N; Soares I; Salcedo G; Lima MR; Azevedo I; van Spronsen FJ
    Ann Nutr Metab; 2010; 56(3):207-11. PubMed ID: 20215742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical growth in phenylketonuria: I. A retrospective study.
    Holm VA; Knox WE
    Pediatrics; 1979 May; 63(5):694-9. PubMed ID: 312489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of children on classical and medium-chain triglyceride ketogenic diets.
    Neal EG; Chaffe HM; Edwards N; Lawson MS; Schwartz RH; Cross JH
    Pediatrics; 2008 Aug; 122(2):e334-40. PubMed ID: 18676520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early dietary treated patients with phenylketonuria can achieve normal growth and body composition.
    Rocha JC; van Spronsen FJ; Almeida MF; Ramos E; Guimarães JT; Borges N
    Mol Genet Metab; 2013; 110 Suppl():S40-3. PubMed ID: 24183791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
    Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
    Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of a new amino acid mixture in the diet therapy of patients with classical phenylketonuria].
    Riva E; Paccanelli S; Longhi R; Giovannini M
    Pediatr Med Chir; 1983; 5(6):521-30. PubMed ID: 6681058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term studies of untreated phenylketonuria II: the plasma phenylalanine level.
    Partington MW
    Neuropadiatrie; 1978 Aug; 9(3):255-67. PubMed ID: 581401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth characteristics of children with ectodermal dysplasia syndromes.
    Motil KJ; Fete TJ; Fraley JK; Schultz RJ; Foy TM; Ochs U; Sybert VP
    Pediatrics; 2005 Aug; 116(2):e229-34. PubMed ID: 16061575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.
    Sharman R; Sullivan K; Young R; McGill J
    Dev Neuropsychol; 2010; 35(1):57-65. PubMed ID: 20390592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of rapid increase of phenylalanine intake in older PKU children.
    Beckner AS; Centerwall WR; Holt L
    J Am Diet Assoc; 1976 Aug; 69(2):148-51. PubMed ID: 939895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.
    Gropper SS; Yannicelli S; White BD; Medeiros DM
    Mol Genet Metab; 2004 May; 82(1):76-82. PubMed ID: 15110326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Growth and nutrition: long term follow-up in early treated phenylketonuric and hyperphenylalaninemic children (author's transl)].
    Koepp P; Hinze G; Held KR
    Monatsschr Kinderheilkd; 1981 Mar; 129(3):154-9. PubMed ID: 6112681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical development in patients with phenylketonuria on dietary treatment: a retrospective study.
    Belanger-Quintana A; Martínez-Pardo M
    Mol Genet Metab; 2011 Dec; 104(4):480-4. PubMed ID: 21878401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria.
    Dobbelaere D; Michaud L; Debrabander A; Vanderbecken S; Gottrand F; Turck D; Farriaux JP
    J Inherit Metab Dis; 2003; 26(1):1-11. PubMed ID: 12872834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of physical development in children with classical phenylketonuria].
    Bushueva TV; Borovik TE; Ladodo KS; Kuzenkova LM; Maslova OI; Gevorkyan AK
    Vopr Pitan; 2015; 84(2):34-43. PubMed ID: 26841554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune function in children with classical phenylketonuria and tetrahydrobiopterin deficiencies.
    Karagoz T; Coskun T; Ozalp I; Ozkaya E; Ersoy F
    Indian Pediatr; 2003 Sep; 40(9):822-33. PubMed ID: 14530542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.